Business
Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance
Fourth Quarter, Full-Year 2025 and Selected Highlights: Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year periodFull-Year revenue of $272.3 million, a 36% increase over $199.6 million recorded in 2024GAAP net income of $6.6 million in Q4 2025, and net loss $5.1 million for 2025Adjusted EBITDA of $24.2 million in Q4 2025, and $61.9 million for 2025Generated $43.9 million of operating cash flow in 2025, versus $(22.2) million used in operations
About this update from Harrow, Inc.
[{"type":"image","alt":"Harrow, Inc.","displaySize":"","headline":null,"caption":"Harrow, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":158,"url":"https://media.zenfs.com/en/globenewswire.com/5c70a4ce2372c78fe8eac93acf26691f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ydPSLlO9mYGzfoj8dx3okA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5c70a4ce2372c78fe8eac93acf26691f","width":300,"height":158}},"lazy":false},{"type":"text","content":"Fourth Quarter, Full-Year 2025 and Selected Highlights: ","length":55,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year period","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"Full-Year revenue of $272.3 million, a 36% increase over $199.6 million recorded in 2024","length":88,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP net income of $6.6 million in Q4 2025, and net loss $5.1 million for 2025","length":78,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA of $24.2 million in Q4 2025, and $61.9 million for 2025","length":71,"tagName":"p"}]},{"val":[{"type":"text","content":"Generated $43.9 million of operating cash flow in 2025, versus $(22.2) million used in operations in 2024","length":105,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash and cash equivalents of $72.9 million as of December 31, 2025","length":66,"tagName":"p"}]},{"val":[{"type":"text","content":"Full-year 2026 revenue guidance of $350 million to $365 million, including $133 million to $153 million in the first half of 2026 and $203 million to $226 million in the second half of 2026","length":189,"tagName":"p"}]},{"val":[{"type":"text","content":"Full-year 2026 Adjusted EBITDA guidance of $80 million to $100 million","length":70,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":777,"olType":false},{"type":"text","content":"A Media Snippet accompanying this announcement is available by clicking on this link.","length":85,"tagName":"p"},{"type":"text","content":"NASHVILLE, Tenn., March 02, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, announced results for the fourth quarter and full-yea...